FZD4 and hepatocellular carcinoma: Yao et al indicated that overexpressed FZD4 could contribute to HCC progression, while overexpression of miR-1827 could suppress the expression of FZD4 in HCC cells, indicating that miR-1827 may display an antitumor effect in HCC [27].